ALLMedicine™ Colitis Center
Research & Reviews 12,158 results
https://doi.org/10.1007/s11894-021-00809-2 10.1136/gut.31.1.54 10.2147/CEG.S173130 10.1016/j.cgh.2017.05.050 10.1097/MPG.0000000000000865 10.1097/00004836-200205000-00014 10.5009/gnl17056 10.1016/j.anai.2019.11.018 10.1016/j.bpg.2007.11.010 10.1016/j.jaci.2003.10.047 10.1038/86365 10.1016/S1074-7613(00)80294-0 10.1182/blood-2002-05-1488 10.1016/j.jped.2018.11.012 10.1016/j.cgh.2011.07.017 10.1016/j.cgh.2010.04.022 10.1097/MEG.0000000000001241 10.14309/crj.0000000000000344 10.1007/s10620-018-4978-7 10.1007/s10620-019-05961-4 10.4103/1319-3767.32185 10.4172/2157-7412.1000230 10.2169/internalmedicine.2298-18 10.1053/j.gastro.2014.07.046 10.1016/S2468-1253(18)30005-0 10.1016/j.dld.2014.11.009 10.1038/modpathol.2010.221 10.1016/j.gtc.2014.02.007 10.1007/s10620-019-05961-4 10.1016/j.cgh.2007.05.015 10.5056/jnm15174 10.1111/j.1440-1827.1985.tb00617.x 10.1111/jgh.13463 10.3329/jhpn.v25i4.616 10.1016/j.pedneo.2011.06.006 10.3748/wjg.v9.i12.2813 10.1007/BF01213260 10.1016/j.jaci.2019.11.007 10.1097/MPG.0000000000000766 10.1038/ajg.2014.166 10.1016/j.gtc.2014.02.013 10.1016/j.jaip.2019.01.053 10.4292/wjgpt.v7.i4.513 10.1097/00042737-200104000-00021 10.1097/00005176-200403000-00021 10.1186/1471-230X-9-32 10.3748/wjg.15.2156 10.1016/0002-9343(91)80010-J 10.1155/2009/565293 10.1016/j.jaci.2004.08.027 10.1016/j.jaci.2011.11.044 10.1016/S0091-6749(03)80986-7 10.1016/j.jaci.2012.07.027 10.1016/j.jaci.2013.02.042 10.1016/j.anai.2018.07.030 10.1016/j.jaci.2007.06.015 10.1097/MPG.0b013e3182801e60 10.1007/s10620-019-05706-3 10.1016/j.cgh.2018.03.024 10.1007/s10620-019-05617-3 10.1056/NEJMoa2012047 10.4168/aair.2017.9.4.360 10.1053/j.gastro.2018.10.051 10.1097/MEG.0b013e32825a6ab4 10.1080/003655201317097254 10.1016/j.alit.2015.06.002 10.1371/journal.pone.0050037 10.1159/000024306 10.1067/mai.2001.114705 10.1016/S0091-6749(03)80936-3 10.3748/wjg.v20.i43.16368 10.1111/all.12096 10.1016/j.anai.2019.02.022 10.1016/j.cgh.2019.05.014 10.1177/003693309003500601 10.1155/2015/691904
Current Gastroenterology Reports; Chen PH, Anderson L et. al.
Aug 1st, 2021 - Eosinophilic gastritis/gastroenteritis (EG/EGE) are rare eosinophilic infiltrative disorders in children and adults that fall under the umbrella term eosinophilic gastrointestinal disorders (EGIDs). EGIDs also include eosinophilic esophagitis (EoE...
https://doi.org/10.1007/s10620-021-07176-y 10.1016/j.cgh.2013.01.021 10.1097/MIB.0b013e3182a0ea54 10.1038/s41598-020-58807-9 10.1002/ibd.21580 10.5664/jcsm.26656 10.1186/s40064-016-3408-6 10.1007/s10620-013-2890-8 10.1016/j.cgh.2013.10.019 10.1111/j.1440-1746.2006.04820.x 10.1080/13548506.2020.1869796 10.1007/s00384-018-3032-8 10.1016/j.cgh.2017.12.027 10.1016/0165-1781(89)90047-4 10.1016/S1389-9457(02)00016-3 10.1001/archinte.163.2.205 10.1152/japplphysiol.00660.2005 10.1016/j.sleep.2008.10.007 10.1016/j.sleep.2014.03.025 10.1016/S1389-9457(00)00065-4 10.1093/sleep/34.5.601 10.1177/0748730415597520 10.1016/j.sleep.2018.08.002 10.1177/0748730403259849 10.1177/0748730405283154 10.5664/jcsm.26801 10.5395/rde.2013.38.1.52 10.3390/jcm9092921 10.1016/j.sleep.2011.10.033 10.1016/j.jsmc.2008.02.001 10.1007/s10620-018-5237-7 10.1093/sleep/30.2.213 10.1111/apha.13161 10.1007/s40675-018-0113-8 10.1016/j.jsmc.2015.05.004 10.1093/sleep/33.9.1159 10.1016/j.smrv.2012.09.005 10.7326/M15-2175 10.1001/archinte.164.17.1888 10.1176/appi.ajp.159.1.5 10.7326/M15-1246 10.5665/sleep.1872 10.1001/jamapsychiatry.2016.3249 10.1093/crocol/otaa052 10.3109/09540261.2014.902808 10.2147/NSS.S169312 10.1016/j.cgh.2014.02.016 10.1371/journal.pone.0156666 10.1016/j.pain.2008.01.025 10.1016/j.jpain.2013.08.007 10.1016/j.smrv.2017.08.001 10.5664/jcsm.7000
Digestive Diseases and Sciences; Salwen-Deremer JK, Smith MT et. al.
Aug 1st, 2021 - Poor sleep is common in inflammatory bowel disease (IBD), predicting increased risk of flares, surgery, and/or hospitalization and reducing quality of life. To profile specific sleep disorder symptoms in IBD, informing intervention efforts. 312 ad...
Inflammatory Bowel Diseases; Santos AL, Lopes S et. al.
Aug 1st, 2021 - The ACE (Albumin, CRP, and Endoscopy) Index in Acute Colitis: Simplify to a Better Prognostic Prediction.|2021|Santos AL,Lopes S,Peixoto A,Garrido I,Medas R,|
International Immunopharmacology; Mohamed NI, Suddek GM et. al.
Jul 31st, 2021 - Ulcerative colitis (UC) is a subcategory of intestinal inflammatory bowel disease characterized by up-regulation of proinflammatory cytokines and oxidative stress. The current study was designed to assess the probable protective effect of the nitr...
https://doi.org/10.1007/s12026-021-09214-3 10.5217/ir.2018.16.1.265 10.3748/wjg.v22.i20.4794 10.1016/S1937-6448(10)83005-9 10.1074/jbc.M110.187815 10.1158/0008-5472.CAN-07-6325 10.7314/APJCP.2014.15.8.3415 10.1016/j.prp.2015.12.018 10.1016/j.gene.2016.12.016 10.1016/j.clcc.2014.09.008 10.1038/srep42723 10.1371/journal.pone.0231988 10.1136/gut.2005.082909 10.1111/sji.12962 10.1007/s12026-016-8804-z 10.1111/j.1365-2362.2011.02491.x 10.1016/j.yexmp.2018.10.010 10.1152/ajplung.00301.2014
Immunologic Research; Fonseca-Camarillo G, Furuzawa-Carballeda J et. al.
Jul 31st, 2021 - The gene of A-kinase anchor protein 12 (AKAP12) regulates cell cycle progression, cell motility, and morphology through its multiple scaffolding domains. However, the role of AKAP12 expression in ulcerative colitis (UC) patients has not been yet d...
Guidelines 30 results
Journal of Crohn's & Colitis; Ng SC, Mak JWY et. al.
Oct 22nd, 2020 - Endoscopy is an essential component in the management of inflammatory bowel disease [IBD]. There is a risk of SARS-CoV-2 transmission during endoscopic procedures. The International Organization for the study of IBD [IOIBD] has developed 11 positi...
Gastroenterology Dougan M, Wang Y et. al.
Oct 21st, 2020 - Immune checkpoint inhibitors (ICIs) have transformed the treatment landscape for oncology, leading to durable remissions in a subset of patients, but also a broad range of potentially life-threatening inflammatory toxicities, many of which involve...
Supportive Care in Cancer : Official Journal of the Multi... Dougan M, Blidner AG et. al.
Aug 29th, 2020 - Immune-related adverse events (IrAEs) affecting the gastrointestinal (GI) tract and liver are among the most frequent and most severe inflammatory toxicities from contemporary immunotherapy. Inflammation of the colon and or small intestines (enter...
Mar 29th, 2020 - Pharmacological Management of Adult Outpatients With Moderate to Severely Active Ulcerative Colitis: Clinical Decision Support Tool.|2020| ,|
Gastroenterology Feuerstein JD, Isaacs KL et. al.
Mar 15th, 2020 - Spotlight: Management of Moderate-to-Severe Ulcerative Colitis.|2020|Feuerstein JD,Isaacs KL,Schneider Y,Siddique SM,Falck-Ytter Y,|
Drugs 769 results see all →
Clinicaltrials.gov 470 results
May 6th, 2020 - Over 1 million people suffer from IBD in the United States. Although the exact pathogenesis is unclear, IBD results from an inappropriate inflammatory response to intestinal microbes which is influenced by the environment in a genetically suscepti...
May 6th, 2020 - Study M15-722 is a Phase 2a study to investigate the efficacy and safety of ABBV-323 in participants with moderate to severe UC who failed prior therapy.
May 5th, 2020 - This study is a follow up study for subjects with Ulcerative Colitis (UC) in stable remission designed to evaluate flexible dosing of CP-690,550.
May 5th, 2020 - This is a Phase 2a, double-blind, placebo-controlled, parallel group study in subjects with active ulcerative colitis and a non-remission (partial) response to infliximab. All enrolled subjects must have been on infliximab for a minimum of 14 week...
May 1st, 2020 - The objectives of Sub-Study 1 are to evaluate the efficacy, safety, and pharmacokinetics of risankizumab as induction treatment in subjects with moderately to severely active ulcerative colitis (UC), and to identify the appropriate induction dose ...
News 1,084 results
Jul 21st, 2021 - NEW YORK (Reuters Health) - Researchers at Progenity, Inc, in San Diego, California, are developing a new way to deliver drugs for inflammatory bowel disease (IBD) directly to the colonic mucosa, which could increase the accuracy of drug delivery ...
Jul 13th, 2021 - The Food and Drug Administration has approved pembrolizumab (Keytruda) monotherapy for locally advanced cutaneous squamous cell carcinoma (cSCC) that can't be cured by surgery or radiation. The July 6 approval for the programmed death–1 inhibitor ...
Jul 7th, 2021 - NEW YORK (Reuters Health) - Upadacitinib, an oral selective Janus kinase (JAK)-1 inhibitor, may reduce symptoms and improves quality of life in patients with ulcerative colitis (UC), according to a post hoc analysis of data from a clinical trial. ...
Jul 6th, 2021 - NEW YORK (Reuters Health) - Adalimumab is effective and well tolerated in children with moderate-to-severe ulcerative colitis (UC), with "clinically meaningful" rates of clinical remission and response, including steroid-free remission and mucosal...
Jun 29th, 2021 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...